arginyl-glycyl-aspartic acid and Gallbladder Neoplasms

arginyl-glycyl-aspartic acid has been researched along with Gallbladder Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abei, M; Fukuda, K; Hamada, H; Hyodo, I; Kawashima, R; Murata, T; Seo, E; Tanaka, N; Ugai, H; Wakayama, M; Yokoyama, KK	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Gallbladder Neoplasms

Article	Year
E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, May-15, Volume: 13, Issue:10 Topics: Adenoviridae; Adenovirus E1A Proteins; Adenovirus E1B Proteins; Animals; Biliary Tract; Cell Line, Tumor; Enterovirus; Gallbladder Neoplasms; Hepatocytes; Humans; Mice; Oligopeptides; Oncolytic Virotherapy; Oncolytic Viruses; Receptors, Virus; Transduction, Genetic; Virus Replication; Xenograft Model Antitumor Assays	2007

Article

Year

E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, May-15, Volume: 13, Issue:10

Topics: Adenoviridae; Adenovirus E1A Proteins; Adenovirus E1B Proteins; Animals; Biliary Tract; Cell Line, Tumor; Enterovirus; Gallbladder Neoplasms; Hepatocytes; Humans; Mice; Oligopeptides; Oncolytic Virotherapy; Oncolytic Viruses; Receptors, Virus; Transduction, Genetic; Virus Replication; Xenograft Model Antitumor Assays

2007